Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis

Clinical and Experimental Allergy

Volumn 36, Issue 5, 2006, Pages 676-684

  Barnes, M L ^a   Ward, J H ^a   Fardon, T C ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Clinical relevance; Fluticasone propionate; Levocetirizine dihydrochloride; Minimal clinically important difference; Seasonal allergic rhinitis

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOSTEROID; FLUTICASONE; HISTAMINE H1 RECEPTOR ANTAGONIST; LEVOCETIRIZINE; NITRIC OXIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EPISTAXIS; FEMALE; HAY FEVER; HUMAN; LETHARGY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; CETIRIZINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EOSINOPHILS; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INHALATION; MALE; MIDDLE AGED; NITRIC OXIDE; NOSE; PIPERAZINES; POLLEN; QUALITY OF LIFE; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 33646268187     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02478.x     Document Type: Article

References (32)

1. Bousquet J Van Cauwenberge P Khaltaev N Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 2001 108 5 Suppl S147 334
2. Akerlund A Andersson M Leflein J Lildholdt T Mygind N Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication J Allergy Clin Immunol 2005 115 S460 82
3. Howarth PH A comparison of the anti-inflammatory properties of intranasal corticosteroids and antihistamines in allergic rhinitis Allergy 2000 55 Suppl. 62 6 11
4. Ratner PH van Bavel JH Martin BG et al A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis J Fam Pract 1998 47 118 25
5. Di Lorenzo G Pacor ML Pellitteri ME et al Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis Clin Exp Allergy 2004 34 259 67
6. Juniper EF Thompson AK Ferrie PJ Roberts JN Development and validation of the mini rhinoconjunctivitis quality of life questionnaire Clin Exp Allergy 2000 30 132 40
7. Juniper EF Guyatt GH Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 1991 21 77 83
8. Payne DN Nitric oxide in allergic airway inflammation Curr Opin Allergy Clin Immunol 2003 3 133 7
9. ATS/ERS recommendations for standardized procedures for the online, offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 Am J Respir Crit Care Med 2005 171 912 30
10. Wilson A Dempsey OJ Sims EJ Coutie WJ Paterson MC Lipworth BJ Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow Clin Exp Allergy 2000 30 833 8
11. Wilson AM Orr LC Sims EJ Lipworth BJ Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis Clin Exp Allergy 2001 31 61 8
12. Wilson AM Dempsey OJ Sims EJ Lipworth BJ A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma Clin Exp Allergy 2001 31 616 24
13. Juniper EF Stahl E Doty RL Simons FER Allen DB Howarth PH Clinical outcomes and adverse effect monitoring in allergic rhinitis J Allergy Clin Immunol 2005 115 S390 413
14. Guyatt GH Kirshner B Jaeschke R Measuring health status what are the necessary measurement properties? J Clin Epidemiol 1992 45 1341 5
15. Sims EJ Wilson AM White PS Gardiner Q Lipworth BJ Short-term repeatability and correlates of laboratory measures of nasal function in patients with seasonal allergic rhinitis Rhinology 2002 40 66 8
16. Wilson AM Sims EJ Robb F Cockburn W Lipworth BJ Peak inspiratory flow rate is more sensitive than acoustic rhinometry or rhinomanometry in detecting corticosteroid response with nasal histamine challenge Rhinology 2003 41 16 20
17. Howarth PH Persson CGA Meltzer EO Jacobson MR Durham SR Silkoff PE Objective monitoring of nasal airway inflammation in rhinitis J Allergy Clin Immunol 2005 115 S414 41
18. Jaffuel D Demoly P Gougat C et al Transcriptional potencies of inhaled glucocorticoids Am J Respir Crit Care Med 2000 162 57 63
19. Stellato C Atsuta J Bickel CA Schleimer RP An in vitro comparison of commonly used topical glucocorticoid preparations J Allergy Clin Immunol 1999 104 3 Part 1 623 9
20. Day JH Briscoe MP Rafeiro E Ratz JD Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU) Int J Clin Pract 2004 58 109 18
21. Grant JA Riethuisen JM Moulaert B DeVos C A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo suppression of histamine-induced weal-and-flare response during 24 h in healthy male subjects Ann Allergy Asthma Immunol 2002 88 190 7
22. Horak F Zieglmayer PU Zieglmayer R Kavina A Lemell P Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration Br J Clin Pharmacol 2005 60 24 31
23. Stubner P Zieglmayer R Horak F A direct comparison of he efficacy of antihistamines in SAR and PAR randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the vienna challenge chamber (VCC) Curr Med Res Opin 2004 20 891 902
24. Fumagalli F Baiardini I Pasquali M et al Antihistamines do they work? Further well-controlled trials involving larger samples are needed Allergy 2004 59 74 7
25. Jaeschke R Singer J Guyatt GH Measurement of health status. Ascertaining the minimal clinically important difference Control Clin Trials 1989 10 407 15
26. Kelleher CJ Pleil AM Reese PR Burgess SM Brodish PH How much is enough and who says so? BJOG 2004 111 605 12
27. Cohen J Statistical power analysis for the behavioral sciences 2nd ed Hillsdale, NJ Lawrence Erlbaum Associates 1998
28. White P Smith H Baker N Davis W Frew A Symptom control in patients with hay fever in UK general practice how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 1998 28 266 70
29. Wilson AM Dempsey OJ Sims EJ Lipworth BJ Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis Ann Allergy Asthma Immunol 2000 85 111 4
30. Xyzal Summary of Product Characteristics UP, Watford, UK.
31. Gross G Jacobs RL Woodworth TH Georges GC Lim JC Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seasonal allergic rhinitis Ann Allergy Asthma Immunol 2002 89 56 62
32. Bachert C Bousquet J Canonica GW et al Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis J Allergy Clin Immunol 2004 114 838 44